Expertise in
2
conditions

Marion A. Simpson

Heidelberg, VIC, AU 
Expertise in
2
conditions
Heidelberg, VIC, AU 
OverviewLocationsClinical Research

Overview

Marion Simpson practices in Heidelberg, Australia. Simpson is highly rated in 2 conditions, according to our data. Their top areas of expertise are Creutzfeldt-Jakob Disease, Dementia, Severe Acute Respiratory Syndrome (SARS), Stroke, and Thrombectomy.

Their clinical research consists of co-authoring 28 peer reviewed articles and participating in 2 clinical trials. MediFind looks at clinical research from the past 15 years.

Locations

Heidelberg, VIC, Australia
Other Locations
Melbourne, VIC, Australia
Parkville, NSW 3010, Australia
St. Albans, Royal North Shore Hospital And Kolling Institute, Royal North Shore Hospital, St. Leonards, Sydney, NSW, Australia
Parkville, VIC, Australia

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

EXTEND-IA TNK: Extending the Time for Thrombolysis in Emergency Neurological Deficits - Intra-Arterial Using Intravenous Tenecteplase Part 2
EXTEND-IA TNK: Extending the Time for Thrombolysis in Emergency Neurological Deficits - Intra-Arterial Using Intravenous Tenecteplase Part 2
Enrollment Status: Completed
Publish Date: March 04, 2020
Intervention Type: Drug
Study Phase: Phase 2
Extending the Time for Thrombolysis in Emergency Neurological Deficits - Intra-Arterial Using Intravenous Tenecteplase
Extending the Time for Thrombolysis in Emergency Neurological Deficits - Intra-Arterial Using Intravenous Tenecteplase
Enrollment Status: Completed
Publish Date: March 30, 2018
Intervention Type: Drug
Study Phase: Phase 2
View 1 Less Clinical Trial

28 Total Publications

Optimism in inclusion body myositis: a double-blind randomised controlled phase III trial investigating the effect of sirolimus on disease progression in patients with IBM as measured by the IBM Functional Rating Scale.
Optimism in inclusion body myositis: a double-blind randomised controlled phase III trial investigating the effect of sirolimus on disease progression in patients with IBM as measured by the IBM Functional Rating Scale.
Journal: Clinical and experimental rheumatology
Published: November 08, 2024

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Simpson's expertise for a condition
ConditionClose
      Want to save this expert for later?
      Sign Up
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile